Literature DB >> 35258408

Are Pain and Negative Affect Coping Distinct Motives for Opioid Misuse?

R Kathryn McHugh1,2, Alexandra Chase1, Catherine D Trinh1, Roger D Weiss1,2.   

Abstract

Background: Coping with pain is a commonly reported motive for opioid misuse. Opioids also provide relief of stress and negative affect and thus are often misused to cope with these emotional states. Although several studies have investigated coping motives in people who misuse opioids, it remains unclear whether pain coping and negative affect coping are distinct or overlapping motives for misuse.
Objectives: In this study, we examined opioid use motives (enhancement, social, negative affect coping, and pain coping) in a sample of 52 adults seeking treatment for opioid use disorder. We used an adaptation of the Drug Use Motives Questionnaire that included an additional 5 items to assess pain coping motives for use.
Results: Results indicated that pain coping was not significantly associated with other motives for use, including negative affect coping. Pain coping motives were strongly correlated with both pain severity (r = .51) and pain interference (r = .39), but not anxiety severity. Conversely, negative affect coping motives were strongly correlated with anxiety severity (r = .45), but not pain severity or interference. Conclusions: These results suggest that pain coping motives may be distinct from negative affect coping motives and should be assessed separately.

Entities:  

Keywords:  Opioid use disorder; coping; motives; negative affect; pain

Mesh:

Substances:

Year:  2022        PMID: 35258408      PMCID: PMC9069863          DOI: 10.1080/10826084.2022.2046094

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.362


  19 in total

1.  Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain.

Authors:  Margaret L Griffin; Katherine A McDermott; R Kathryn McHugh; Garrett M Fitzmaurice; Robert N Jamison; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2016-04-25       Impact factor: 4.492

2.  Development and validation of the opioid prescription medication motives questionnaire: a four-factor model of reasons for use.

Authors:  Rachel E Jones; Alexander Spradlin; R Joe Robinson; Sarah L Tragesser
Journal:  Psychol Addict Behav       Date:  2014-09-01

3.  Normative data for common pain measures in chronic pain clinic populations: closing a gap for clinicians and researchers.

Authors:  Michael K Nicholas; Daniel S J Costa; Megan Blanchard; Hilarie Tardif; Ali Asghari; Fiona M Blyth
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

4.  Alcohol use disorder and motives for prescription opioid misuse: A latent class analysis.

Authors:  Victoria R Votaw; R Kathryn McHugh; Katie Witkiewitz
Journal:  Subst Use Misuse       Date:  2019-05-07       Impact factor: 2.164

5.  Some norms and reliability data for the State--Trait Anxiety Inventory and the Zung Self-Rating Depression scale.

Authors:  R G Knight; H J Waal-Manning; G F Spears
Journal:  Br J Clin Psychol       Date:  1983-11

6.  Test-retest reliabilities of State-Trait Anxiety Inventory in a stressful social analogue situation.

Authors:  W R Rule; M D Traver
Journal:  J Pers Assess       Date:  1983-06

7.  Cue-induced craving in dependence upon prescription opioids and heroin.

Authors:  R Kathryn McHugh; Sara Park; Roger D Weiss
Journal:  Am J Addict       Date:  2014-03-15

8.  Persistent pain is associated with substance use after detoxification: a prospective cohort analysis.

Authors:  Mary Jo Larson; Michael Paasche-Orlow; Debbie M Cheng; Christine Lloyd-Travaglini; Richard Saitz; Jeffrey H Samet
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

9.  Validation of the Brief Pain Inventory for chronic nonmalignant pain.

Authors:  Gabriel Tan; Mark P Jensen; John I Thornby; Bilal F Shanti
Journal:  J Pain       Date:  2004-03       Impact factor: 5.820

10.  Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample.

Authors:  Ty S Schepis; A S De Nadai; J A Ford; S E McCabe
Journal:  Epidemiol Psychiatr Sci       Date:  2020-01-29       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.